#USA #San Francisco #URAC #Pharmacy Benefit Management #SmithRx

SmithRx Achieves URAC Accreditation in Pharmacy Benefit Management

SmithRx, a contemporary leader in the pharmacy benefits management (PBM) sector, recently announced a significant milestone - the attainment of URAC's Pharmacy Benefit Management Accreditation. This esteemed designation underscores SmithRx's commitment to delivering high-quality healthcare solutions while pushing the envelope of traditional pharmacy benefits models.

Founded in 2016, SmithRx has consistently aimed to revamp the legacy PBM framework by prioritizing transparency and trust in its operations. URAC, recognized as a leading independent authority in healthcare quality, evaluates organizations based on rigorous standards, ensuring they meet high expectations for practices, consumer protections, and operational integrity. By passing this strict evaluation, SmithRx has demonstrated its unwavering dedication to quality care and improved healthcare outcomes.

As one of the first 25 PBMs to receive this accreditation, SmithRx pioneers a path toward enhanced pharmacy benefit solutions. The company's innovative platform not only identifies and secures cost-effective medications but also employs extensive partnerships within the pharmacy benefits industry to ensure significant savings. To date, SmithRx has supported over 5,000 employer clients and has realized over $320 million in savings in 2025 alone, averaging a reduction of over 20% in pharmacy benefit costs per client.

CEO and founder of SmithRx, Jake Frenz, remarked on the achievement: “For the past decade, we have challenged the norms of the PBM industry, which has often operated behind opaque models. With URAC’s validation, our claims of prioritizing our customers and their members are now substantiated by an independent reviewer. This accreditation highlights our dedication to transparency while meeting the necessary standards for quality and patient safety.”

URAC’s approval signifies a thorough assessment of SmithRx's governance, clinical practices, and operational protocols. Shawn Griffin, MD, President and CEO of URAC, highlighted the importance of accountability in healthcare, stating, “SmithRx’s achievement showcases how a transparent PBM model can align with rigorous standards for quality.”

SmithRx’s model aims to dismantle the conventional PBM framework typically riddled with hidden fees and complexities. By passing through 100% of discounts and rebates to clients while providing real-time pricing information and comprehensive savings reports, the company empowers clients to make informed decisions that lead to substantial financial savings. This approach fosters a more equitable and efficient healthcare system, aligning with SmithRx’s core mission of making healthcare more accessible and affordable.

Looking ahead, SmithRx is excited to continue its innovative trajectory in the pharmacy benefits landscape, underscoring the potential of transparency as a foundational principle in healthcare. The recent URAC accreditation serves as a beacon of validation for SmithRx’s ongoing efforts to transform the industry for the better, establishing a robust methodology for ensuring that quality healthcare solutions are accessible to all.

About SmithRx

SmithRx stands at the forefront of the modern PBM landscape, transforming how organizations manage pharmacy benefits. The company operates on principles of radical transparency, aiming to simplify the complexities of pharmacy spending while ensuring that clients retain control over their costs. For more information about their offerings and vision, visit SmithRx’s website.

About URAC

URAC, a non-profit established in 1990, has been a leader in healthcare quality and patient safety, offering a variety of accreditation programs across the industry. Their rigorous standards are developed in cooperation with industry stakeholders to ensure that accredited organizations not only meet but exceed expectations in delivering high-quality healthcare services.